Recent studies suggest that Chi3l1 is a novel neutrophil autoantigenic target in IBD, whereas IgA and secretory IgA (sIgA) to Chi3l1 may facilitate the serological diagnosis of IBD [99,100]. This evidence concerns the gene CD79A and inflammatory bowel disease.